- Home
- DOW vs ZTS Comparison
DOW vs ZTS Comparison
Compare DOW & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOW | ZTS |
|---|---|---|
| Founded | 1897 | 1952 |
| Country | United States | United States |
| Employees | 35700 | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8B | 32.5B |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | DOW | ZTS |
|---|---|---|
| Price | $30.74 | $76.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 12 |
| Target Price | $39.13 | ★ $154.18 |
| AVG Volume (30 Days) | ★ 8.9M | 5.5M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.54% | 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 3.08 |
| Revenue | ★ $39,968,000,000.00 | $9,467,000,000.00 |
| Revenue This Year | $5.40 | $5.63 |
| Revenue Next Year | $2.33 | $4.77 |
| P/E Ratio | ★ N/A | $25.05 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $20.67 | $71.00 |
| 52 Week High | $42.74 | $156.49 |
Technical Indicators
Market Signals| Indicator | DOW | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.41 | 51.07 |
| Support Level | $28.71 | $73.02 |
| Resistance Level | $35.51 | $78.74 |
| Average True Range (ATR) | 0.88 | 2.92 |
| MACD | 0.10 | 0.33 |
| Stochastic Oscillator | 36.88 | 60.76 |
Price Performance
Historical ComparisonAbout DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in consumer and industrial end markets.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.